Puma Biotechnology (PBYI) Property, Plant & Equipment (Net) (2011 - 2026)

Puma Biotechnology (PBYI) Property, Plant & Equipment (Net) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Puma Biotechnology 409.56 Mn 371.27 Mn 34.39 Mn 124,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 124,000.00
Mar 31, 2026 124,000.00
Dec 31, 2025 187,000.00
Dec 31, 2025 187,000.00
Sep 30, 2025 305,000.00
Sep 30, 2025 305,000.00
Jun 30, 2025 388,000.00
Jun 30, 2025 388,000.00
Mar 31, 2025 474,000.00
Mar 31, 2025 474,000.00
Dec 31, 2024 515,000.00
Dec 31, 2024 515,000.00
Sep 30, 2024 601,000.00
Sep 30, 2024 601,000.00
Jun 30, 2024 680,000.00
Jun 30, 2024 680,000.00
Mar 31, 2024 757,000.00
Mar 31, 2024 757,000.00
Dec 31, 2023 855,000.00
Dec 31, 2023 855,000.00